Suchergebnisse - "Fajgenbaum, David C"

PubPharm (11)

1

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Hematology. American Society of Hematology. Education Program | 2018

von Fajgenbaum, D.

2

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von Fajgenbaum, D.

3

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von van Rhee, F. | Voorhees, P. | Dispenzieri, A. | +39

CommentIn: Blood. 2018 Nov 15;132(20):2109-2110. - PMID 30442745

4

A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease

enthalten in: Blood advances | 2018

von Baker, T. | Gambino, K. | Schriefer, L. | +5

5

Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease

enthalten in: Annals of hematology | 2018

von Dong, Y. | Zhang, L. | Nong, L. | +6

6

Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman disease

enthalten in: American journal of hematology | 2018

von Pierson, S. | Stonestrom, A. | Shilling, D. | +8

7

Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease

enthalten in: Annals of hematology | 2018

von Dong, Y. | Zhang, L. | Nong, L. | +6

8

Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease

enthalten in: Annals of hematology | 2018

von Dong, Y. | Zhang, L. | Nong, L. | +6

9

Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease

enthalten in: Annals of hematology | 2018

von Dong, Y. | Zhang, L. | Nong, L. | +6

10

Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference

enthalten in: Frontiers in medicine | 2018

von Lee, J. | Werth, V. | Hall, R. | +14